Y-mAbs Therapeutics, Inc. - Common Stock (NQ:YMAB)

8.610 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 15, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	8.610
Bid (Size)	8.590 (245)
Ask (Size)	8.610 (40)
Prev. Close	8.610
Today's Range	8.610 - 8.610
52wk Range	8.610 - 8.610
Shares Outstanding	44,789,076
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNT, DAY, WOW, YMAB on Behalf of Shareholders

August 26, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verint Systems Inc. (Nasdaq – VRNT), Dayforce, Inc. (NYSE – DAY), WideOpenWest, Inc. (NYSE – WOW), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)

August 26, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Performance

More News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DAY, WOW, YMAB, STAA on Behalf of Shareholders

August 21, 2025

From Halper Sadeh LLC

Via GlobeNewswire

A Look Ahead: Y-mAbs Therapeutics's Earnings Forecast ↗

August 07, 2025

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Dayforce, Inc. (NYSE- DAY), WideOpenWest, Inc. (NYSE - WOW), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)

August 21, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, TASK, YMAB on Behalf of Shareholders

August 20, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB

August 19, 2025

From Kahn Swick & Foti, LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. (NYSE - WOW), BankFinancial Corporation (Nasdaq - BFIN), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)

August 12, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes ↗

August 08, 2025

Via Benzinga

The trading volume of these stocks is deviating from the norm in today's session. ↗

August 08, 2025

Via Chartmill

Shareholder Alert: The Ademi Firm Investigates Whether Y-mAbs Therapeutics Inc. is Obtaining a Fair Price for its Public Shareholders

August 08, 2025

From Ademi & Fruchter LLP

Via Business Wire

Y-mAbs (YMAB) Q2 Revenue Falls 14% ↗

August 08, 2025

Via The Motley Fool

Earnings Scheduled For August 8, 2025 ↗

August 08, 2025

Via Benzinga

Y-MABS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB

August 07, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Unusual volume stocks are being observed in Wednesday's session. ↗

August 06, 2025

Via Chartmill

Here are the top movers in Tuesday's session. ↗

August 05, 2025

Via Chartmill

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, YMAB, BASE, CORZ on Behalf of Shareholders

August 05, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Nasdaq Down 50 Points; ISM Services PMI Declines In July ↗

August 05, 2025

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)

August 05, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 05, 2025

Via Benzinga

Tuesday's session: top gainers and losers ↗

August 05, 2025

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

August 05, 2025

Via Chartmill

Dow Surges Over 100 Points; Pfizer Earnings Top Views ↗

August 05, 2025

Via Benzinga

YMAB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Y-mAbs Therapeutics, Inc. Is Fair to Shareholders

August 05, 2025

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 01, 2025

Via Benzinga

Frequently Asked Questions

Is Y-mAbs Therapeutics, Inc. - Common Stock publicly traded?

Yes, Y-mAbs Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Y-mAbs Therapeutics, Inc. - Common Stock trade on?

Y-mAbs Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Y-mAbs Therapeutics, Inc. - Common Stock?

The ticker symbol for Y-mAbs Therapeutics, Inc. - Common Stock is YMAB on the Nasdaq Stock Market

What is the current price of Y-mAbs Therapeutics, Inc. - Common Stock?

The current price of Y-mAbs Therapeutics, Inc. - Common Stock is 8.610

When was Y-mAbs Therapeutics, Inc. - Common Stock last traded?

The last trade of Y-mAbs Therapeutics, Inc. - Common Stock was at 09/15/25 04:00 PM ET

What is the market capitalization of Y-mAbs Therapeutics, Inc. - Common Stock?

The market capitalization of Y-mAbs Therapeutics, Inc. - Common Stock is 385.63M

How many shares of Y-mAbs Therapeutics, Inc. - Common Stock are outstanding?

Y-mAbs Therapeutics, Inc. - Common Stock has 386M shares outstanding.